Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02792998 · ClinicalTrials.gov registry record · Phase 1

A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects

A Phase 1 study of Healthy, sponsored by Cyclerion Therapeutics.

Completed
Registry status
Phase 1
Development phase
67
Enrollment target
1
Study location

NCT02792998 is a Phase 1 study of Healthy that has completed, run by Cyclerion Therapeutics. The registered enrollment target is 67 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02792998, a Phase 1 study of Healthy, has completed, sponsored by Cyclerion Therapeutics.

COMPLETED
Registry status
Phase 1
Development phase
67 participants
Enrollment target
1
Study location

Study Summary

The objectives of this study are: Stage 1: To assess the safety, tolerability, pharmacokinetic (PK) profile and pharmacodynamic (PD) effects of a range of doses of IW-1701 tablets administered orally to healthy subjects over 7 days of repeated dosing Stage 2: To assess the safety, tolerability, PK profile and PD effects of IW-1701 tablets administered orally to healthy subjects, in fed and fasted states, in an open-label, single-dose, 2-period, 2-sequence crossover study.

Conditions Studied

Healthy

Interventions

  • DRUG Placebo
  • DRUG IW-1701

Study Locations (1)

Texas

  • ICON Early Phase Unit - San Antonio

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2016-05
Est. Completion 2016-11
Phase Phase 1

Sponsor

Cyclerion Therapeutics

11 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02792998

The ClinicalTrials.gov registry entry for NCT02792998 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (90% lower). The listed sponsor is Cyclerion Therapeutics, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02792998 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02792998 about?

NCT02792998 is a clinical study titled "A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects". The objectives of this study are: Stage 1: To assess the safety, tolerability, pharmacokinetic (PK) profile and pharmacodynamic (PD) effects of a range of doses of IW-1701 tablets administered orally to healthy subjects over 7 days of repeated dosing Stage 2: To assess the safety, tolerability, PK...

What is the current status of trial NCT02792998?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 67 participants. The study started on 2016-05. Estimated completion is 2016-11.

What conditions does trial NCT02792998 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02792998?

The interventions under investigation include: Placebo (DRUG), IW-1701 (DRUG).

Who is sponsoring clinical trial NCT02792998?

This trial is sponsored by Cyclerion Therapeutics, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02792998 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.